While debate is going on in courts on ban on 344 FDC products. The government should share with public and all stakeholders in the industry, the 500 more FDC combinations, which are under consideration. This will help stakeholders in Pharma Industry to debate and plan their investments in a considered manner instead of facing financial loss which comes with a sudden ban.